Millennium Management
ATXS

Millennium Management’s Astria Therapeutics ATXS Stock Holding History

Millennium Management’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-70,000
Closed -$626K – 5840
2024
Q4 		$626K Buy
70,000
+32,600
+87% +$346K ﹤0.01% 4566
2024
Q3 		$412K Buy
+37,400
New +$416K ﹤0.01% 4978

Millennium Management's ATXS Position: Q1 2026 in Review

Millennium Management sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 534,054 shares — an estimated $6.99M sold.

Millennium Management first reported a position in ATXS in Q2 2015 and held it in 27 quarters. The position peaked at $27.4M in Q3 2024. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

  • Millennium Management reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 534,054 Astria Therapeutics shares in Q1 2026, an estimated $6.99M.
  • Millennium Management first reported a position in Astria Therapeutics in Q2 2015 and held it in 27 quarters.
  • Millennium Management's Astria Therapeutics position peaked at $27.4M in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.